Implementing methadone maintenance treatment in prisons in Malaysia;La aplicación del tratamiento de mantenimiento con metadona en prisiones de Malasia

Bulletin of the World Health Organization

Volumn 91, Issue 2, 2013, Pages 124-129

  Wickersham, Jeffrey A ^a   Marcus, Ruthanne ^a   Kamarulzaman, Adeeba ^b   Zahari, Muhammad Muhsin ^b   Altice, Frederick L ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; METHADONE; TUBERCULOSTATIC AGENT;

DISEASE TREATMENT; DRUG; EDUCATION; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; TRAINING; TUBERCULOSIS;

ADULT; ARTICLE; COMMUNITY BASED REHABILITATION; CONTROLLED STUDY; CORRECTIONAL STAFF; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; EDUCATION PROGRAM; FEMALE; HARM REDUCTION; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INMATE; MAINTENANCE THERAPY; MALAYSIA; MALE; MEDICAL PERSONNEL; NAUSEA; NONMEDICAL OCCUPATIONS; PATIENT CARE; PHASE 3 CLINICAL TRIAL; PILOT STUDY; PREVALENCE; PRISONER; PUBLIC HEALTH SERVICE; REINFORCEMENT; SOMNOLENCE; TRAINING; TREATMENT DURATION; TUBERCULOSIS; VOMITING;

KELANTAN; MALAYSIA; SELANGOR; WEST MALAYSIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84873295839     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.109132     Document Type: Article

References (17)

1. Malaysia country advocacy brief: injecting drug use and HIV. Geneva: Joint United Nations Programme on HIV/AIDS; 2009.
2. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010;376:367-87. doi:10.1016/S0140-6736(10)60829-X
3. Hedrich D, Alves P, Farrell M, Stöver H, Møller L, Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 2012;107:501-17. doi:10.1111/j.1360-0443.2011.03676.x
4. Merrall EL, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010;105:1545-54. doi:10.1111/j.1360-0443.2010.02990.x
5. Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry 2006;63:102-9. doi:10.1001/archpsyc.63.1.102
6. Schwartz RP, Kelly SM, O'Grady KE, Mitchell SG, Peterson JA, Reisinger HS et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict 2008;17:396-401. doi:10.1080/10550490802268835
7. Dolan KA, Wodak AD, Hall WD. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev 1998;17:153-8. doi:10.1080/09595239800186951
8. Howells C, Allen S, Gupta J, Stillwell G, Marsden J, Farrell M. Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone. Drug Alcohol Depend 2002;67:169-76. doi:10.1016/S0376-8716(02)00024-8
9. Kerr T, Jurgens R. Methadone maintenance therapy in prisons: reviewing the evidence. Montreal: Canadian HIV/AIDS Legal Network; 2004.
10. Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O'Grady KE. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat 2009;37:277-85. doi:10.1016/j.jsat.2009.03.002
11. Gorta A. Monitoring the New South Wales methadone program: 1986-1991. New South Wales: Department of Corrective Services; 1992.
12. Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS 2010;21:416-23. doi:10.1258/ijsa.2009.009180
13. Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy 2007;18:136-40. doi:10.1016/j.drugpo.2006.12.015
14. Noordin NM, Merican MI, Rahman HA, Lee SS, Ramly R. Substitution treatment in Malaysia. Lancet 2008;372:1149-50. doi:10.1016/S0140-6736(08)61479-8
15. Wickersham JA, Zahari MM, Azar MM, Kamarulzaman A, Altice FL. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend 2013. In press.
16. Mohamad N, Bakar NH, Musa N, Talib N, Ismail R. Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy. Harm Reduct J 2010;7:30. doi:10.1186/1477-7517-7-30
17. Springer SA, Azar MM, Altice FL. HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse 2011;37:12-21. doi:10.3109/00952990.2010.540280